X0202 SCHEDULE 13G 0002123249 XXXXXXXX LIVE Common Stock, $0.001 par value 10/14/2026 0001479419 KALA BIO, Inc. 483119301 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 Rule 13d-1(c) Labkowski Nachum X1 966991.00 0.00 966991.00 0.00 966991.00 5.0 IN The amount set forth in rows (5), (7) and (9) include (i) 57,21 common shares ("Common Shares") of Kala Bio, Inc. (the "Issuer") directly held by the reporting person, and (ii) 909,720 Common Shares held by Halevi Enterprises LLC, a Delaware limited liability company, which the reporting person has sole voting and sole dispositive power over. The percentage set forth in row (11) is calculated based on 19,339,786 Common Shares of the Issuer issued and outstanding of as August 14, 2026 as reported in the Quarterly Report on Form 10-Q filed by the Issuer with the Securities and Exchange Commission on August 19, 2026. KALA BIO, Inc. 1167 MASSACHUSETTS AVENUE, ARLINGTON, MASSACHUSETTS, 02476. Nachum Labkowski 360 Main Street, 30th Floor Winnipeg, Manitoba, Canada R3C 4G1 United States of America Y 966,991 5% 966,991 0 966,991 0 Y N Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Labkowski Nachum Nachum Labkowski 10/19/2026